ALSTODT LANCE
SEC CIK 1756228 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BRTX | BioRestorative Therapies, Inc. | Pres, CEO, COB, Dir, 10% | 187.5K | $124.9K | — | 34 | 2021-11-16 | 2025-10-06 |
Most active insiders at BRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ALSTODT LANCE | Pres, CEO, COB, Dir, 10% | — | — |
| 2 | Silva Francisco | VP of Research, Development, Dir | — | — |
Transactions 34
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-20 | 2025-10-06 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir, 10% | A - Grant | $1.60 | +15.6K | 187.5K | +9% | +$25.0K |
| 2024-03-20 | 2024-03-18 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | F - Tax | $1.39 | -17.6K | 171.9K | -9% | -$24.5K | |
| 2023-09-18 | 2023-09-15 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir, 10% | P - Purchase | $1.70 | +2,200 | 189.5K | +1% | +$3,740 | |
| 2023-09-13 | 2023-09-13 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir, 10% | P - Purchase | $1.53 | +800 | 188.1K | +0.4% | +$1,224 | |
| 2023-09-06 | 2023-09-06 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir, 10% | P - Purchase | $1.96 | +2,887 | 187.3K | +2% | +$5,659 | |
| 2023-07-25 | 2023-07-25 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir, 10% | P - Purchase | $2.44 | +4,200 | 184.4K | +2% | +$10.2K | |
| 2023-03-22 | 2023-03-20 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir, 10% | F - Tax | $2.92 | -6,729 | 180.2K | -4% | -$19.6K | |
| 2023-02-27 | 2023-02-18 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir, 10% | F - Tax | $2.99 | -374 | 186.9K | -0.2% | -$1,118 | |
| 2023-02-02 | 2023-02-01 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $3.10 | +400 | 187.3K | +0.2% | +$1,240 | |
| 2023-01-30 | 2023-01-27 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $3.01 | +200 | 186.9K | +0.1% | +$602 | |
| M | 2023-01-24 | 2023-01-20 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $3.13 | +200 | 186.7K | +0.1% | +$627 |
| M | 2023-01-20 | 2023-01-18 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $3.11 | +400 | 186.4K | +0.2% | +$1,245 |
| 2023-01-10 | 2023-01-09 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $3.08 | +100 | 186.1K | +0.1% | +$308 | |
| M | 2022-12-28 | 2022-12-23 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $3.01 | +300 | 185.9K | +0.2% | +$903.00 |
| 2022-12-07 | 2022-12-07 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $2.99 | +1,800 | 185.7K | +1.0% | +$5,382 | |
| 2022-11-21 | 2022-11-18 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $2.88 | +1,000 | 183.9K | +0.5% | +$2,880 | |
| M | 2022-09-23 | 2022-09-22 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $2.92 | +200 | 182.9K | +0.1% | +$584 |
| 2022-07-13 | 2022-07-12 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $2.95 | +700 | 182.7K | +0.4% | +$2,065 | |
| 2022-07-01 | 2022-06-30 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $3.10 | +1,100 | 182.0K | +0.6% | +$3,410 | |
| 2022-06-17 | 2022-06-16 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $3.73 | +600 | 180.9K | +0.3% | +$2,238 | |
| 2022-06-15 | 2022-06-14 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $3.91 | +500 | 179.6K | +0.3% | +$1,955 | |
| 2022-06-15 | 2022-06-15 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $3.68 | +700 | 180.3K | +0.4% | +$2,576 | |
| M | 2022-06-14 | 2022-06-13 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $3.95 | +200 | 179.0K | +0.1% | +$790 |
| 2022-06-09 | 2022-06-08 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $4.28 | +100 | 178.9K | +0.1% | +$428 | |
| 2022-06-03 | 2022-06-01 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $4.60 | +200 | 178.8K | +0.1% | +$920.00 | |
| 2022-05-27 | 2022-05-26 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $3.52 | +2,700 | 178.6K | +2% | +$9,504 | |
| M | 2022-05-02 | 2022-05-02 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $3.95 | +400 | 175.9K | +0.2% | +$1,580 |
| 2022-03-22 | 2022-03-18 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | A - Grant | — | +12.4K | 175.5K | +8% | — | |
| 2022-01-24 | 2022-01-24 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $3.40 | +1,470 | 163.1K | +0.9% | +$4,998 | |
| 2022-01-05 | 2022-01-05 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $3.85 | +2,000 | 161.6K | +1% | +$7,700 | |
| 2021-12-02 | 2021-12-01 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $5.50 | +799 | 159.6K | +0.5% | +$4,394 | |
| 2021-11-23 | 2021-11-23 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $6.00 | +2,500 | 158.8K | +2% | +$15.0K | |
| 2021-11-22 | 2021-11-22 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $6.31 | +396 | 156.3K | +0.3% | +$2,499 | |
| M | 2021-11-16 | 2021-11-16 | BRTX | BioRestorative Therapies, Inc. | ALSTODT LANCE | Pres, CEO, COB, Dir | P - Purchase | $6.71 | +4,500 | 154.2K | +3% | +$30.2K |
Purchase Sale Sale after option exercise All abbreviations